{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Antiviral", "Autohaemotherapy", "COVID-19", "Ozone therapy", "Pulmonary diseases"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33115670", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "10", "Day": "25"}], "ELocationID": ["10.1016/j.virusres.2020.198207", "S0168-1702(20)31114-X"], "Journal": {"ISSN": "1872-7492", "JournalIssue": {"Volume": "291", "PubDate": {"Year": "2021", "Month": "Jan", "Day": "02"}}, "Title": "Virus research", "ISOAbbreviation": "Virus Res"}, "ArticleTitle": "Ozone therapy in COVID-19: A narrative review.", "Pagination": {"StartPage": "198207", "MedlinePgn": "198207"}, "Abstract": {"AbstractText": ["The main objective of this narrative review is to describe the available evidence on the possible antiviral activity of ozone in patients with COVID-19 and its therapeutic applicability through hospital protocols. Amongst different possible therapies for SARS-CoV-2 pneumonia, ozone therapy seems to have an immunological role because of the modulation of cytokines and interferons, including the induction of gamma interferon. Some data suggest the possible role of ozone therapy in SARS, either as a monotherapy or, more realistically, as an adjunct to standard treatment regimens; therefore, there is increasing interest in the role of ozone therapy in COVID-19 treatment The PubMed and Scopus databases and the Italian Scientific Society of Oxygen Ozone Therapy website were used to identify articles focused on ozone therapy. The search was limited to articles published from January 2011 to July 2020. Of 280 articles found on ozone therapy, 13 were selected and narratively reviewed. Ozone exerts antiviral activity through the inhibition of viral replication and direct inactivation of viruses. Ozone is an antiviral drug enhancer and is not an alternative to antiviral drugs. Combined treatment with involving ozone and antivirals demonstrated a reduction in inflammation and lung damage. The routes of ozone administration are direct intravenous, major autohaemotherapy and extravascular blood oxygenation-ozonation. Systemic ozone therapy seems useful in controlling inflammation, stimulating immunity and as antiviral activity and providing protection from acute coronary syndromes and ischaemia reperfusion damage, thus suggesting a new methodology of immune therapy. Systemic ozone therapy in combination with antivirals in COVID-19-positive patients may be justified, helpful and synergic."], "CopyrightInformation": "Copyright \u00a9 2020. Published by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S.C. Farmacia Ospedaliera, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "Cattel", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S.C. Farmacia Ospedaliera, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "Giordano", "ForeName": "Susanna", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S.C. Farmacia Ospedaliera, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "Bertiond", "ForeName": "Cecilia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Sciences, Infectious Diseases, University of Turin, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy. Electronic address: tommaso.lupia89@gmail.com."}], "LastName": "Lupia", "ForeName": "Tommaso", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Sciences, Infectious Diseases, University of Turin, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy; Tufts University School of Medicine, Boston, MA, USA."}], "LastName": "Corcione", "ForeName": "Silvia", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S.C. Farmacia Ospedaliera, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "Scaldaferri", "ForeName": "Matilde", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Direzione Sanitaria d'Azienda, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "Angelone", "ForeName": "Lorenzo", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Sciences, Infectious Diseases, University of Turin, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy."}], "LastName": "De Rosa", "ForeName": "Francesco Giuseppe", "Initials": "FG"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Virus Res", "NlmUniqueID": "8410979", "ISSNLinking": "0168-1702"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors report no declarations of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bhimraj et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19; Clinical Infectious Diseases, ciaa478, https://doi.org/10.1093/cid/ciaa478 Published: 27 April 2020.", "ArticleIdList": ["PMC7197612", "32338708"]}, {"Citation": "Bocci V., Zanardia I., Valacchi G., Borrelli E., Travagli V. Validity of oxygen-ozone therapy as integrated medication form in chronic inflammatory diseases. Cardiovasc. Hematol. Disord. Drug Targets. 2015;15(2):127\u2013138. doi: 10.2174/1871529x1502151209114642. PMID: 26126818.", "ArticleIdList": ["10.2174/1871529x1502151209114642", "26126818"]}, {"Citation": "Bocci V., Zanardi I., Travagli V. Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Med. Gas Res. 2011;1(April 28 (1)):6. doi: 10.1186/2045-9912-1-6. PubMed PMID: 22146387; PubMed Central PMCID: PMC3231820.", "ArticleIdList": ["10.1186/2045-9912-1-6", "PMC3231820", "22146387"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 2009;29(July (4)):646\u2013682. doi: 10.1002/med.20150. PMID: 19260079.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Conti P., Gallenga C.E., Tet\u00e8 G., Caraffa A., Ronconi G., Younes A., Toniato E., Ross R., Kritas S.K. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J. Biol. Regul. Homeost. Agents. 2020;34(March 31 (2)) doi: 10.23812/Editorial-Conti-2. [Epub ahead of print] PubMed PMID: 32228825.", "ArticleIdList": ["10.23812/Editorial-Conti-2", "32228825"]}, {"Citation": "Di Mauro R., Cantarella G., Bernardini R., Di Rosa M., Barbagallo I., Distefano A., Longhitano L., Vicario N., Nicolosi D., Lazzarino G., Tibullo D., Gulino M.E., Spampinato M., Avola R., Li Volti G. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int. J. Mol. Sci. 2019;20(February 1 (3)) doi: 10.3390/ijms20030634. pii: E634.Review. PubMed PMID:30717203; PubMed Central PMCID: PMC6387239.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}, {"Citation": "Elvis A.M., Ekta J.S. Ozone therapy: a clinical review. J. Nat. Sci. Biol. Med. 2011;2(January (1)):66\u201370. doi: 10.4103/0976-9668.82319. PubMed PMID: 22470237; PubMed Central PMCID: PMC3312702.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Flanagan J.P., Gradisar I.A., Gross R.J., TR Kelly. Air Embolus--a lethal complication of subclavian venipuncture. New England J. Med. 1969 Aug 28.", "ArticleIdList": ["5796967"]}, {"Citation": "Gali\u00e8 M., Costanzo M., Nodari A., Boschi F., Calderan L., Mannucci S., Covi V., Tabaracci G., Malatesta M. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic. Biol. Med. 2018;20(124):114\u2013121. doi: 10.1016/j.freeradbiomed.2018.05.093. Aug Epub 2018 Jun 2. PubMed PMID: 29864481.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.05.093", "29864481"]}, {"Citation": "Hern\u00e1ndez Rosales F.A., Calunga Fern\u00e1ndez J.L., Turrent Figueras J., Men\u00e9ndez Cepero S., Montenegro Perdomo A. Ozone therapy effects on biomarkers and lung function in asthma. Arch. Med. Res. 2005;36(September-October(5)):549\u2013554. doi: 10.1016/j.arcmed.2005.04.021. PMID: 16099337.", "ArticleIdList": ["10.1016/j.arcmed.2005.04.021", "16099337"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(February 15 (10223)):497\u2013506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:. PubMed PMID: 31986264; PubMed Central PMCID: PMC7159299.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Lupia T., Scabini S., Mornese Pinna S., Di Perri G., De Rosa F.G., Corcione S. Novel coronavirus (2019-nCoV) outbreak: a new challenge. J. Glob. Antimicrob. Resist. 2019;2020(21):22\u201327. doi: 10.1016/j.jgar.2020.02.0.", "ArticleIdList": ["10.1016/j.jgar.2020.02.0", "PMC7102618", "32156648"]}, {"Citation": "mn Mawsouf, tt Tanbouli. Vielbahn-h\u00e4nsler ozone therapy in patients with viral hepatitis C: ten year\u2019s experience. Ozone Sci Eng. 2012;34(6):451\u2013458. doi: 10.1080/01919512.2012.720161.", "ArticleIdList": ["10.1080/01919512.2012.720161"]}, {"Citation": "Petry G., Rossato L.G., Nespolo J., Kreutz L.C. Dallazem Bertol C in vitro inactivation of herpes virus by ozone. Ozone Sci Eng. 2014;36(3):249\u2013252. doi: 10.1080/01919512.2013.862165.", "ArticleIdList": ["10.1080/01919512.2013.862165"]}, {"Citation": "Rowen R.J. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med. Gas Res. 2019;9(October-December (4)):232\u2013237. doi: 10.4103/2045-9912.273962. Review. PubMed PMID: 31898609.", "ArticleIdList": ["10.4103/2045-9912.273962", "PMC7802416", "31898609"]}, {"Citation": "Rowen R.J., Robins H. A plausible \u201cpenny\u201d costing effective treatment for corona virus- ozone therapy. J Infect Dis Epidemiol. 2020;6:113. doi: 10.23937/2474-3658-1510113.", "ArticleIdList": ["10.23937/2474-3658-1510113"]}, {"Citation": "Sagai M., Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med. Gas Res. 2011;20(1):29. doi: 10.1186/2045-9912-1-29. Dec PubMed PMID: 22185664; PubMed Central PMCID: PMC3298518.", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Smith N.L., Wilson A.L., Gandhi J., Vatsia S., Khan S.A. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 2017;7(October 17 (3)):212\u2013219. doi: 10.4103/2045-9912.215752. eCollection 2017 Jul-Sep. Review. PubMed PMID: 29152215; PubMed Central PMCID: PMC5674660.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Del Pup L., Lleshi A., Berretta M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue - A short report. Eur. Rev. Med. Pharmacol. Sci. 2018;22(November (22)):8030\u20138033. doi: 10.26355/eurrev_201811_16432. PMID: 30536352.", "ArticleIdList": ["10.26355/eurrev_201811_16432", "30536352"]}, {"Citation": "Tortorici M.A., Veesler D. Structural insights into coronavirus entry. Adv. Virus Res. 2019;105:93\u2013116. doi: 10.1016/bs.aivir.2019.08.002. Epub 2019 Aug 22. PubMed PMID: 31522710; PubMed Central PMCID: PMC7112261.", "ArticleIdList": ["10.1016/bs.aivir.2019.08.002", "PMC7112261", "31522710"]}, {"Citation": "Toung T.J., Rossberg M.I., Hutchins G.M. Volume of air in a lethal venous air embolism\". Anesthesiology. 2001;94(2) Feb.", "ArticleIdList": ["11176104"]}, {"Citation": "Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(April 16 (2)):281\u2013292. doi: 10.1016/j.cell.2020.02.058. e6Epub 2020 Mar 9. PubMed PMID: 32155444; PubMed Central PMCID: PMC7102599.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wang Z., Zhang A., Meng W., Wang T., Li D., Liu Z., Liu H. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 2018;15(835):82\u201393. doi: 10.1016/j.ejphar.2018.07.059. Sep Epub 2018 Jul 31. PubMed PMID: 30075224.", "ArticleIdList": ["10.1016/j.ejphar.2018.07.059", "30075224"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(Mar 27 (6485)):1444\u20131448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4. PubMed PMID: 32132184; PubMed Central PMCID: PMC7164635.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Yang Y., Peng F., Wang R., Guan K., Jiang T., Xu G., Sun J., Chang C. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun. 2020;109(102434) doi: 10.1016/j.jaut.2020.102434. May Epub 2020 Mar 3. Review. PubMed PMID: 32143990; PubMed Central PMCID: PMC7126544.", "ArticleIdList": ["10.1016/j.jaut.2020.102434", "PMC7126544", "32143990"]}, {"Citation": "Zaky S., Kamel S.E., Hassan M.S., Sallam N.A., Shahata M.A., Helal S.R., Mahmoud H. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. J. Altern. Complement. Med. 2011;17(March (3)):259\u2013263. doi: 10.1089/acm.2010.0016. PubMed PMID: 21417811.", "ArticleIdList": ["10.1089/acm.2010.0016", "21417811"]}, {"Citation": "SIOOT - Italian Society of Oxygen-Ozone Therapy; http://www.ossigenoozono.it."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "8", "Day": "20"}, {"Year": "2020", "Month": "10", "Day": "20"}, {"Year": "2020", "Month": "10", "Day": "21"}, {"Year": "2020", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "29", "Hour": "5", "Minute": "32"}, {"Year": "2020", "Month": "10", "Day": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33115670", "PMC7585733", "10.1016/j.virusres.2020.198207", "S0168-1702(20)31114-X"]}}], "PubmedBookArticle": []}